Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.83
-0.97 (-11.02%)
May 5, 2025, 10:27 AM EDT - Market open
Ocular Therapeutix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 349.68 | 392.1 | 195.81 | 102.3 | 164.16 | 228.06 | Upgrade
|
| Cash & Short-Term Investments | 349.68 | 392.1 | 195.81 | 102.3 | 164.16 | 228.06 | Upgrade
|
| Cash Growth | -27.58% | 100.25% | 91.41% | -37.68% | -28.02% | 318.94% | Upgrade
|
| Accounts Receivable | 25.22 | 32.39 | 26.18 | 21.33 | 21.14 | 12.25 | Upgrade
|
| Other Receivables | - | 0.18 | - | - | - | - | Upgrade
|
| Receivables | 25.22 | 32.56 | 26.18 | 21.33 | 21.14 | 12.25 | Upgrade
|
| Inventory | 3.27 | 3.04 | 2.31 | 1.97 | 1.25 | 1.2 | Upgrade
|
| Prepaid Expenses | 9.52 | 13.28 | 7.79 | 4.03 | 4.75 | 3.39 | Upgrade
|
| Restricted Cash | - | - | 0.15 | - | - | - | Upgrade
|
| Other Current Assets | - | - | - | - | - | 1.26 | Upgrade
|
| Total Current Assets | 387.69 | 440.99 | 232.24 | 129.63 | 191.3 | 246.16 | Upgrade
|
| Property, Plant & Equipment | 16.61 | 15.33 | 18.21 | 17.9 | 11.82 | 13.94 | Upgrade
|
| Other Long-Term Assets | 1.61 | 1.61 | 1.61 | 1.76 | 1.76 | 1.76 | Upgrade
|
| Total Assets | 405.92 | 457.94 | 252.06 | 149.29 | 204.89 | 261.86 | Upgrade
|
| Accounts Payable | 4.63 | 4.18 | 4.39 | 5.12 | 4.59 | 2.71 | Upgrade
|
| Accrued Expenses | 31.08 | 35.12 | 28.67 | 24.1 | 20.12 | 14.31 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 8.29 | Upgrade
|
| Current Portion of Leases | 2.16 | 1.93 | 1.59 | 1.6 | 1.62 | 1.36 | Upgrade
|
| Current Unearned Revenue | 0.06 | 0.13 | 0.26 | 0.58 | - | - | Upgrade
|
| Total Current Liabilities | 37.93 | 41.35 | 34.9 | 31.4 | 26.34 | 26.66 | Upgrade
|
| Long-Term Debt | 69.2 | 68.51 | 74.93 | 54.01 | 51.44 | 41.24 | Upgrade
|
| Long-Term Leases | 4.87 | 5.35 | 6.88 | 8.68 | 5.92 | 7.55 | Upgrade
|
| Long-Term Unearned Revenue | 14 | 14 | 14.14 | 13.39 | 13 | 12 | Upgrade
|
| Other Long-Term Liabilities | 14 | 13.39 | 30.1 | 6.44 | 20.19 | 98.31 | Upgrade
|
| Total Liabilities | 139.99 | 142.59 | 160.93 | 113.91 | 116.89 | 185.77 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,221 | 1,206 | 788.7 | 652.21 | 633.8 | 615.34 | Upgrade
|
| Retained Earnings | -955.14 | -891.08 | -697.58 | -616.84 | -545.8 | -539.25 | Upgrade
|
| Shareholders' Equity | 265.93 | 315.34 | 91.13 | 35.38 | 88 | 76.1 | Upgrade
|
| Total Liabilities & Equity | 405.92 | 457.94 | 252.06 | 149.29 | 204.89 | 261.86 | Upgrade
|
| Total Debt | 76.22 | 75.78 | 83.39 | 64.28 | 58.98 | 58.44 | Upgrade
|
| Net Cash (Debt) | 273.46 | 316.32 | 112.42 | 38.02 | 105.18 | 169.62 | Upgrade
|
| Net Cash Growth | -33.05% | 181.38% | 195.70% | -63.86% | -37.99% | - | Upgrade
|
| Net Cash Per Share | 1.63 | 2.00 | 1.31 | 0.46 | 1.28 | 2.79 | Upgrade
|
| Filing Date Shares Outstanding | 159.26 | 159.02 | 148.63 | 77.51 | 76.75 | 76.07 | Upgrade
|
| Total Common Shares Outstanding | 159.26 | 157.75 | 114.96 | 77.2 | 76.73 | 76 | Upgrade
|
| Working Capital | 349.77 | 399.63 | 197.34 | 98.23 | 164.96 | 219.5 | Upgrade
|
| Book Value Per Share | 1.67 | 2.00 | 0.79 | 0.46 | 1.15 | 1.00 | Upgrade
|
| Tangible Book Value | 265.93 | 315.34 | 91.13 | 35.38 | 88 | 76.1 | Upgrade
|
| Tangible Book Value Per Share | 1.67 | 2.00 | 0.79 | 0.46 | 1.15 | 1.00 | Upgrade
|
| Machinery | - | 18.05 | 16.78 | 13.75 | 12.28 | 11.47 | Upgrade
|
| Construction In Progress | - | 0.12 | 0.28 | 4.07 | 0.58 | 0.12 | Upgrade
|
| Leasehold Improvements | - | 14.53 | 14.7 | 9.07 | 9.07 | 9.07 | Upgrade
|
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.